|
NIF3L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.099800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.070200E-01 |
| Normal-vs-Stage2 |
6.338400E-01 |
| Normal-vs-Stage3 |
7.796000E-01 |
| Normal-vs-Stage4 |
1.126580E-01 |
| Stage1-vs-Stage2 |
2.331800E-01 |
| Stage1-vs-Stage3 |
2.679800E-01 |
| Stage1-vs-Stage4 |
8.938000E-02 |
| Stage2-vs-Stage3 |
8.543400E-01 |
| Stage2-vs-Stage4 |
4.643400E-01 |
| Stage3-vs-Stage4 |
3.756200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.601800E-01 |
| Normal-vs-AfricanAmerican |
8.291400E-01 |
| Normal-vs-Asian |
9.132800E-01 |
| Caucasian-vs-AfricanAmerican |
8.132000E-01 |
| Caucasian-vs-Asian |
7.676000E-01 |
| AfricanAmerican-vs-Asian |
8.440600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.639800E-01 |
| Normal-vs-Female |
3.343800E-01 |
| Male-vs-Female |
3.133600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.186790E-01 |
| Normal-vs-Extreme_Weight |
9.785500E-02 |
| Normal-vs-Obese |
8.557200E-01 |
| Normal-vs-Extreme_Obese |
4.428200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.336800E-01 |
| Normal_Weight-vs-Obese |
2.419200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.399800E-01 |
| Extreme_Weight-vs-Obese |
2.030800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.051400E-01 |
| Obese-vs-Extreme_Obese |
4.858600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.556100E-02 |
| Normal-vs-Age(41-60Yrs) |
9.401800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.490200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.751200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.155700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.514230E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.396300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.518600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.862000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.636400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.713400E-01 |
| Normal-VS-Type2 PRCC |
1.995430E-01 |
| Normal-VS-KIRP CIMP |
2.535600E-01 |
| Normal-VS-Unclassified PRCC |
5.287200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.374800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.865370E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.592600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.363800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.267760E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.295400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.623700E-02 |
| Normal-vs-N1 |
6.076300E-02 |
| Normal-vs-N2 |
6.189200E-01 |
| N0-vs-N1 |
1.823900E-03 |
| N0-vs-N2 |
7.513600E-01 |
| N1-vs-N2 |
2.968000E-01 |
|
|
